Congress Passes PBM Price Disclosure Measures, PLANSPONSOR

Partner Sage Fattahian and Lindsay Goodman are featured in PLANSPONSOR commenting on Congress’s passage of new pharmacy benefit manager price disclosure measures aimed at increasing transparency in prescription drug pricing.

Sage and Lindsay note that the legislation reflects long‑standing, bipartisan efforts to regulate PBMs at the federal level, emphasizing that plan sponsors will need to closely monitor both legislative and regulatory developments as new disclosure and compliance obligations take shape.

Read the full PLANSPONSOR article >>